Envestnet Asset Management
ANIP icon

Envestnet Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Envestnet Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
14,994
+623
+4% +$50K ﹤0.01% 3490
2026
Q1 		$1.11M Buy
14,371
+7,020
+95% +$548K ﹤0.01% 3416
2025
Q4 		$580K Sell
7,351
-4,163
-36% -$360K ﹤0.01% 3603
2025
Q3 		$1.05M Buy
11,514
+1,188
+12% +$96.9K ﹤0.01% 3299
2025
Q2 		$674K Buy
10,326
+3,869
+60% +$252K ﹤0.01% 3496
2025
Q1 		$432K Buy
6,457
+1,527
+31% +$91.2K ﹤0.01% 3706
2024
Q4 		$273K Buy
4,930
+1,256
+34% +$72.1K ﹤0.01% 3941
2024
Q3 		$219K Buy
+3,674
New +$224K ﹤0.01% 3982
2020
Q1 		– Sell
-13,330
Closed -$822K – 2967
2019
Q4 		$822K Buy
13,330
+639
+5% +$42.3K ﹤0.01% 2151
2019
Q3 		$925K Sell
12,691
-115
-0.9% -$8.6K ﹤0.01% 1991
2019
Q2 		$1.05M Sell
12,806
-971
-7% -$69.1K ﹤0.01% 1909
2019
Q1 		$972K Sell
13,777
-863
-6% -$50.8K ﹤0.01% 1923
2018
Q4 		$659K Buy
+14,640
New +$767K ﹤0.01% 1981
2018
Q3 		– Sell
-2,997
Closed -$199K – 1305
2018
Q2 		$199K Sell
2,997
-239
-7% -$14.9K ﹤0.01% 1666
2018
Q1 		$188K Sell
3,236
-45
-1% -$2.86K ﹤0.01% 1613
2017
Q4 		$211K Sell
3,281
-382
-10% -$23.8K ﹤0.01% 1820
2017
Q3 		$192K Buy
3,663
+326
+10% +$15.5K ﹤0.01% 1855
2017
Q2 		$156K Sell
3,337
-156
-4% -$7.53K ﹤0.01% 1962
2017
Q1 		$172K Buy
3,493
+1,577
+82% +$88.5K ﹤0.01% 1982
2016
Q4 		$117K Sell
1,916
-671
-26% -$41K ﹤0.01% 2117
2016
Q3 		$172K Buy
+2,587
New +$162K ﹤0.01% 2085
2015
Q4 		– Sell
-1,627
Closed -$64K – 2975
2015
Q3 		$64K Buy
+1,627
New +$92.6K ﹤0.01% 2539

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management's ANIP Position: Q2 2026 in Review

Envestnet Asset Management increased its ANI Pharmaceuticals (ANIP) stake by 4.3% in Q2 2026, buying an estimated $50K and bringing the position to 14,994 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3490.

Envestnet Asset Management first reported a position in ANIP in Q3 2015 and has held it in 22 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Envestnet Asset Management held 14,994 shares of ANI Pharmaceuticals worth $1.24M as of Q2 2026.
  • Envestnet Asset Management bought 623 ANI Pharmaceuticals shares in Q2 2026, an estimated $50K.
  • ANI Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3490 holding.
  • Envestnet Asset Management first reported a position in ANI Pharmaceuticals in Q3 2015 and has held it in 22 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.